Gambro concludes clinics acquisition

Gambro concludes clinics acquisition Stockholm, Sweden - Gambro AB (Stockholm Stock Exchange: GAMBaST, GAMBbST), a leading international medical technology and healthcare company, today announced that its subsidiary GAMBRO Healthcare Inc. has acquired the dialysis clinics owned by USHAWL, Inc. ("USHAWL") and Century Dialysis Corporation ("Century"). USHAWL and Century are wholly owned subsidiaries of Salick @ Health Care, Inc. , a provider of outpatient dialysis and cancer services. Gambro previously announced that it had reached an agreement to acquire these clinics. USHAWL operates 12 outpatient dialysis clinics within Southern California in Los Angeles, Orange, Riverside and San Bernadino counties that serve approxi- mately 900 patients. Century provides in-hospital dialysis services within the same area under contracted arrangements to more than 25 hospitals. For further information please contact: Bengt Modéer, Senior Vice President, Corporate Communications, tel. +46-8-613 65 00, +46-70-513 65 33 Anna Augustson, European Investor Relations Manager, tel. +46-8-613 65 35, +46-70-513 65 34 Tim Schoenberg, Vice President, US Investor Relations Manager, +1-949-425-2185 Gambro is a global medical technology and healthcare company with leading positions in renal care - services and products - and blood component technology (BCT). Gambro is the second largest provider of kidney dialysis services in the world. Gambro treats about 41,800 patients in 569 clinics worldwide. Renal care products comprise dialyzers, dialysis machines, blood lines and dialysis fluid. BCT includes products for the separation and handling of blood components. The group, with revenue of approximately SEK 18 billion (USD 2.2 billion), has approximately 17,000 employees in some 40 countries. ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/1999/06/02/19990602BIT00020/bit0001.pdf http://www.bit.se/bitonline/1999/06/02/19990602BIT00020/bit0002.doc

About Us

Gambro is a global medical technology and healthcare company with leading positions in renal care - services and products - and blood component technology. The group, with revenue of approximately SEK 18 billion (USD 2.2 billion), has approximately 17,000 employees in some 40 countries.

Subscribe